Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: The Role of Cerebellar Hyperactivity in Parkinson's Disease

View source ↗

Summary

The study evaluating cerebellar hyperactivity in Parkinson's disease has completed, with results posted on 2019-02-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Parkinson's Disease | Status: COMPLETED | Results posted: 2019-02-15